Fmoc-L-Lys(Me2)-OH*HCl is an Fmoc-protected, free amino acid derivative of L-lysine bearing a dimethyl-substituted side-chain on the ε-amino group, with the carboxyl group present as a free acid and the overall compound isolated as a hydrochloride salt. The molecule contains an Fmoc (9-fluorenylmethoxycarbonyl) carbamate protecting group on the α-amino functionality, while the ε-amino group is N,N-dimethylated, and the salt form indicates protonation of a basic site to support handling and solubility. In peptide chemistry, this protected lysine analogue functions as a building block for stepwise incorporation into peptides during solid-phase or solution-phase synthesis, where the Fmoc group provides chemoselective control over amide-bond formation while the dimethylated side chain offers a defined tertiary amine handle for structure-activity studies and downstream derivatization.
CAT No: CP25662
CAS No:252049-10-8
Synonyms/Alias:252049-10-8;FMOC-LYS(ME)2-OHHCL;Fmoc-N',N'-dimethyl-L-lysinehydrochloride;Fmoc-Lys(me)2-OH.HCl;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(dimethylamino)hexanoicacidhydrochloride;FMOC-Lys(Me)2-OH;Fmoc-Arg(Me)2-OH.HCl;Fmoc-L-Lys(Me2)-OH*HCl;CTK8C5187;Fmoc-Lys(Me)2-OH.HCl;MolPort-006-705-670;ANW-74502;AKOS015899921;RTR-011536;VA50376;AK-49612;SC-65063;AB0057669;FT-0080058;FT-0602163;I14-11868;N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6,N6-dimethyl-L-lysinehydrochloride;(2S)-6-(dimethylamino)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hexanoicacidhydrochloride
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-dimethyl-L-lysine hydrochloride
Fmoc-L-Lys(Me2)-OH·HCl is an Fmoc-protected lysine derivative bearing a dimethyl-substituted side chain, supplied as the hydrochloride salt to ensure handling stability of the basic ε-amino functionality. The structure combines a stereochemically defined L-configuration at the α-carbon with an Fmoc carbamate on the α-amine, a carboxylic acid suitable for peptide bond formation, and a protected or substituted lysine side-chain motif that can be selectively engaged for downstream derivatization. The salt form moderates amine basicity and supports reproducible coupling behavior in peptide synthesis workflows, while the Fmoc group provides orthogonal protection for iterative N-terminal assembly. The dimethylated side-chain pattern influences sterics and hydrophobic character, enabling controlled access to lysine-like positions in peptide analogs, chiral intermediates, and synthetic building blocks.
1. Peptide Synthesis
Fmoc-L-Lys(Me2)-OH·HCl supports solid-phase and solution-phase peptide assembly where Fmoc deprotection exposes a reactive α-amine for coupling. The presence of a free carboxylic acid enables standard amide bond formation, while the L-configuration preserves stereochemical fidelity of the lysine-derived residue in peptide chains. The hydrochloride salt form can help maintain consistent reactivity of the basic side-chain environment during activation and coupling steps, reducing variability from acid-base equilibria. The dimethyl-substituted lysine side chain can be incorporated to tune steric bulk and hydrophobicity in peptide building block preparation, supporting peptide analog construction for structure-focused studies and synthetic methodology development.
2. Side-Chain Functionalization
Fmoc-L-Lys(Me2)-OH·HCl is applicable to side-chain functionalization strategies that leverage the lysine-derived substitution pattern and the orthogonally protected α-amino group. The Fmoc carbamate enables selective N-deprotection without directly disturbing the side-chain substitution, allowing sequential modification logic aligned with peptide chemistry protecting-group strategies. The dimethyl-substituted motif can serve as a handle for constructing hydrophobic pockets, modulating conformational preferences, or directing subsequent transformations that introduce additional functionality at the lysine position. Downstream use can include generation of functionalized peptide fragments, chiral amino acid intermediates, and derivatized scaffolds for chemical biology research and peptidomimetic construction.
3. Chemical Biology Probes
Fmoc-L-Lys(Me2)-OH·HCl can be employed in chemical biology workflows to build peptide-based probes with lysine-site substitution patterns that affect binding and labeling behavior. The Fmoc-protected α-amine and carboxylic acid support incorporation into defined peptide sequences, where stereochemical control of the L-amino acid center helps maintain predictable conformations. The hydrochloride salt form facilitates reproducible handling during synthesis of labeled or modified biomolecule fragments, while the dimethyl side-chain substitution can influence local polarity and membrane association tendencies relevant to probe design. The resulting peptide analogs can be used as research intermediates for biomolecule interaction studies, receptor-binding mapping, and molecular recognition investigations in applied biochemical research.
4. Pharmaceutical Manufacturing
Fmoc-L-Lys(Me2)-OH·HCl fits pharmaceutical intermediate preparation and process chemistry contexts where protected amino acid building blocks are manufactured and consumed in controlled peptide synthesis. The Fmoc protection strategy provides an established orthogonal protection logic for iterative manufacturing of peptide intermediates, and the carboxylic acid functionality supports downstream coupling steps under standardized activation conditions. The hydrochloride salt form can improve storage and dosing consistency for basic amino acid derivatives within production supply chains, while the defined stereochemistry supports predictable impurity profiles tied to chiral amino acid intermediates. The dimethylated lysine side-chain pattern enables manufacturing routes to peptide analogs with tailored physicochemical properties, supporting specialty chemical production of defined peptide fragments used in research-grade and process development programs.
5. Process Chemistry Intermediate
Fmoc-L-Lys(Me2)-OH·HCl is suitable for process chemistry intermediate preparation where robust protection-group behavior and predictable functional group reactivity are required. The Fmoc carbamate offers a controllable N-protection state for peptide building block preparation, while the α-carboxylic acid enables conversion into activated coupling partners or direct incorporation into peptide sequences. The L-configuration and salt form help constrain variability associated with amino acid handling, supporting reproducible downstream synthetic steps in fine chemical synthesis. The dimethyl-substituted side-chain motif can be leveraged to access chiral amino acid derivatives and peptide intermediates that feed into broader peptidomimetic construction and industrial chemical manufacturing of functional molecules.
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.